Sartorius Stedim Biotech S.A. Stock OTC Markets
Stocks
SRTOY
US80386Y1010
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.54 USD | -7.21% |
|
-12.51% | -22.00% |
| 11:10am | Sartorius Stedim Biotech: Equipment inflects, margins beat - but guidance optics cloud the print |  |
| 07:06am | SARTORIUS STEDIM BIOTECH : Buy rating from RBC | ZD |
| Market Cap | 17.06B 19.39B 15.84B 14.57B 27.33B 1,878B 27.82B 189B 73.9B 916B 72.8B 71.23B 3,178B | P/E 2026 * |
44.6x | P/E 2027 * | 35x |
|---|---|---|---|---|---|
| Enterprise Value | 19.4B 22.05B 18.02B 16.57B 31.08B 2,136B 31.64B 215B 84.04B 1,042B 82.79B 81B 3,614B | EV / Sales 2026 * |
6.13x | EV / Sales 2027 * | 5.39x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.59% |
Last Transcript: Sartorius Stedim Biotech S.A.
| 1 day | -7.21% | ||
| 1 week | -12.51% | ||
| Current month | -10.30% | ||
| 1 month | +3.58% | ||
| 3 months | -0.47% | ||
| 6 months | -23.39% | ||
| Current year | -22.00% |
| 1 week | 18.28 |  | 21.6 |
| 1 month | 18.28 | | 21.76 |
| Current year | 17.25 | | 26.54 |
| 1 year | 17.25 | | 26.54 |
| 3 years | 15.75 | | 31.8 |
| 5 years | 15.75 | | 43.52 |
| 10 years | 15.75 | | 43.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.21% | -12.51% | - | - | 19.47B | |
| -0.02% | +2.22% | -19.72% | -11.87% | 175B | |
| +0.18% | -1.73% | -10.75% | -7.49% | 105B | |
| +0.77% | -1.39% | +3.50% | +58.63% | 58.48B | |
| -0.82% | -1.93% | +38.23% | +58.17% | 51.36B | |
| -0.06% | -4.38% | -16.24% | -45.38% | 42.2B | |
| -0.07% | -10.09% | - | - | 31.44B | |
| -1.27% | -9.64% | -18.48% | -44.83% | 27.56B | |
| +0.49% | +0.18% | +59.73% | -3.45% | 25.32B | |
| +0.68% | -4.16% | -6.01% | -8.72% | 20.52B | |
| Average | -0.72% | +0.60% | +3.78% | -0.62% | 59.65B | |
| Weighted average by Cap. | -0.21% | +3.97% | -4.39% | +0.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 3.6B 2.94B 2.7B 5.07B 349B 5.16B 35.16B 13.71B 170B 13.51B 13.22B 590B | 3.5B 3.97B 3.25B 2.99B 5.6B 385B 5.7B 38.83B 15.14B 188B 14.92B 14.6B 651B |
| Net income | 380M 432M 353M 325M 609M 41.85B 620M 4.22B 1.65B 20.41B 1.62B 1.59B 70.82B | 475M 540M 441M 406M 761M 52.29B 775M 5.28B 2.06B 25.51B 2.03B 1.98B 88.49B |
| Net Debt | 2.34B 2.66B 2.17B 2B 3.75B 258B 3.82B 25.99B 10.14B 126B 9.99B 9.77B 436B | 1.77B 2.01B 1.64B 1.51B 2.83B 195B 2.88B 19.64B 7.66B 94.96B 7.55B 7.38B 329B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$18.54 | -7.21% | 31,822 |
| 26-07-22 | US$19.98 | +4.44% | 16,947 |
| 26-07-21 | US$19.13 | -6.48% | 33,189 |
| 26-07-20 | US$20.46 | -3.67% | 38,320 |
| 26-07-17 | US$21.24 | +0.21% | 12,685 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- SRTOY Stock
Select your edition
All financial news and data tailored to specific country editions
